
HEK293/Human NRP1 Stable Cell
Item | Cat# | Price |
Stable Cell Line | SNB-OT-0005 | $19,800 |
Compound Testing Services | CT-001 | $1,850 per 384w plate (Up To 16 cpds Dose) |
Product Description
Natriuretic Peptide Receptor 1 (NPR1) is a critical receptor for cardiovascular regulation. It is the essential gateway for the heart's hormones (ANP/BNP) to lower blood pressure by driving cGMP production. NPR1 is genetically essential for survival, clinically validated as a life-saving drug target, and physiologically central as the heart's primary self-defense mechanism. Its integrity is fundamental to cardiovascular health, and its modulation represents a cornerstone of advanced cardiovascular therapeutics.
Screeningbio’s HEK293/Human NRP1 cell line overexpress NRP1 and is designed to detect increases in intracellular cGMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cGMP kit can be used to detect the signal.
Product Specifications
Target Type | GPCR |
Species | Human |
HGNC Symbol | NRP1 |
Accession Number | |
Parental Line | HEK293 |
Lot# | See Vial |
Storage | Liquid Nitrogen |
Data
![HEK293/NPR1 Agonist Assay. HEK293/NPR1 cells were treated with reference agonist REGN5381. The assay was run based on Revvity cGMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.](https://static.wixstatic.com/media/cbf7de_76e9c367667d43df848a2093b48164bb~mv2.png/v1/fill/w_75,h_75,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/cbf7de_76e9c367667d43df848a2093b48164bb~mv2.png)
Target Background
Natriuretic Peptide Receptor 1 (NPR1) is a critical receptor for cardiovascular regulation. It is the essential gateway for the heart's hormones (ANP/BNP) to lower blood pressure by driving cGMP production.
NPR1 is genetically essential for survival, clinically validated as a life-saving drug target, and physiologically central as the heart's primary self-defense mechanism. Its integrity is fundamental to cardiovascular health, and its modulation represents a cornerstone of advanced cardiovascular therapeutics.
